Jonathan Murphy Acquires 663 Shares of Assura Plc (LON:AGR) Stock

Key Points

• Jonathan Murphy, an insider at Assura Plc, purchased 663 shares of the company at GBX 49 ($0.65) each on August 5th, totaling approximately £324.87 ($431.95).
• Assura Plc operates over 600 healthcare properties across the UK and Ireland, serving over six million patients.
• The company has achieved B Corp certification as of July 2024, making it the first FTSE 250 business to receive this certification.

Assura Plc (LON:AGR - Get Free Report) insider Jonathan Murphy purchased 663 shares of the firm's stock in a transaction on Tuesday, August 5th. The shares were purchased at an average cost of GBX 49 ($0.66) per share, for a total transaction of £324.87 ($436.77).

Jonathan Murphy also recently made the following trade(s):

• On Wednesday, July 9th, Jonathan Murphy acquired 607 shares of Assura stock. The shares were bought at an average cost of GBX 50 ($0.67) per share, with a total value of £303.50 ($408.04).

Assura Trading Up 0.4%

Assura stock traded up GBX 0.21 ($0.00) during midday trading on Friday, reaching GBX 49.19 ($0.66). The stock had a trading volume of 24,229,340 shares, compared to its average volume of 28,571,775. The stock's 50-day simple moving average is GBX 49.86 and its 200 day simple moving average is GBX 46.77. Assura Plc has a twelve month low of GBX 35.24 ($0.47) and a twelve month high of GBX 50.95 ($0.68). The company has a debt-to-equity ratio of 85.05, a quick ratio of 2.84 and a current ratio of 0.89. The stock has a market capitalization of £1.60 billion, a PE ratio of -47.01, a price-to-earnings-growth ratio of 3.60 and a beta of 0.37.

Assura (LON:AGR - Get Free Report) last posted its earnings results on Monday, July 21st. The real estate investment trust reported GBX 3.50 ($0.05) earnings per share (EPS) for the quarter. Assura had a negative net margin of 18.09% and a negative return on equity of 1.92%. Analysts expect that Assura Plc will post 3.5830389 EPS for the current year.

Assura Company Profile

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served. We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G). Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.